Krasna M J
Division of Thoracic and Cardiovascular Surgery, University of Maryland, School of Medicine, Baltimore, USA.
Oncology (Williston Park). 1996 Jun;10(6):793-802; discussion 804, 813-4.
Staging is extremely important in determining the proper treatment of patients with thoracic malignancies. Staging groups can be used to predict outcome after cancer treatment and allocate patients to appropriate treatment regimens. Thoracoscopy is an excellent means of staging intrathoracic malignancies. It is a good tool for biopsy of mediastinal lymph nodes and evaluation of the pleural cavity. Routine thoracoscopic and laparoscopic lymph node staging have been used in patients with esophageal carcinoma with excellent results. For patients with lung cancer, thoracoscopy augments other noninvasive and minimally invasive staging procedures. It is used as a complement to standard cervical mediastinoscopy in assessing mediastinal and hilar lymph nodes. It can thus help avoid an unnecessary thoracotomy for attempted resection in a patient who is found to have gross spread of locoregional disease.
分期对于确定胸段恶性肿瘤患者的恰当治疗极为重要。分期分组可用于预测癌症治疗后的预后,并将患者分配至合适的治疗方案。胸腔镜检查是对胸内恶性肿瘤进行分期的极佳手段。它是纵隔淋巴结活检及评估胸腔的良好工具。常规胸腔镜和腹腔镜淋巴结分期已应用于食管癌患者,效果良好。对于肺癌患者,胸腔镜检查可辅助其他非侵入性和微创分期程序。在评估纵隔和肺门淋巴结时,它可作为标准颈部纵隔镜检查的补充。因此,对于局部区域疾病已出现广泛播散的患者,它有助于避免为尝试切除而进行不必要的开胸手术。